Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what's happening in the lungs. The research is part of a larger, ongoing project to develop wearable smart medical sensors for monitoring, collecting and interpreting personal health data.
     
 
    
    
    
    
        
        The Office of Research has announced the winners of the inaugural Strategic Collaborative Faculty Grant Program, initiated by the Office of the Assistant Vice President of Research, Strategic Implementation.
     
 
    
    
    
    
        
        GlySens Incorporated announced today that it has secured FDA approval for extending the current human clinical evaluation of its fully implantable continuous glucose monitoring system (the ICGM® System) from the originally approved six-month duration to the system's commercially-intended operational duration of twelve months.
     
 
    
    
    
    
        
        Smartphone applications and wearable sensors have the potential to help people make healthier lifestyle choices, but scientific evidence of mobile health technologies' effectiveness for reducing risk factors for heart disease and stroke is limited, according to a scientific statement from the American Heart Association, published in the association's journal Circulation.
     
 
    
    
    
    
        
        Sensoria Inc, leader in wearable fitness technology, today announced the 2015 line of wearable fitness gear and integrated running system, along with updates to the accompanying Android app. The new line of smart sports bra and t-shirt, along with the newly available running system will improve consistency, accuracy, and user experience, providing customers with greater insights about their running style and physical performance. 
     
 
    
    
    
    
        
        DexCom, Inc., a leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it has entered into an agreement with the life sciences team at Google to jointly develop a series of next-generation CGM products that are designed to be smaller and less expensive than existing technologies. These new products will incorporate Google’s miniaturized electronics platform with DexCom’s best-in-class sensor technology. 
     
 
    
    
    
    
        
        Researchers at MIT’s Koch Institute for Integrative Cancer Research have designed a miniature biochemical sensor, which can be implanted in cancerous tissue during the preliminary biopsy.
     
 
    
    
    
    
        
        Super productive factories of the future could employ fleets of genetically engineered bacterial cells, such as common E. coli, to produce valuable chemical commodities in an environmentally friendly way. By leveraging their natural metabolic processes, bacteria could be re-programmed to convert readily available sources of natural energy into pharmaceuticals, plastics and fuel products.
     
 
    
    
    
    
        
        EncounterCare Solutions is pleased to announce that it has signed a Letter Of Intent to enter into a joint venture with CNV Systems Ltd. (CNV), a Vancouver, B.C. domiciled company, with sub- operations in San Francisco, Taipei, and Shenzhen. CNV specializes in research engineering and production of high efficiency wireless multi-vital-sign sensors for remote health monitoring and preventive care applications.
     
 
    
    
    
    
        
        Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announced today the launch of REPLY CRT-P, its new cardiac resynchronization therapy pacemaker.
     
 
 
    
                    
                
                
                    
    
        Terms
        
            While we only use edited and approved content for Azthena
            answers, it may on occasions provide incorrect responses.
            Please confirm any data provided with the related suppliers or
            authors. We do not provide medical advice, if you search for
            medical information you must always consult a medical
            professional before acting on any information provided.
        
        
            Your questions, but not your email details will be shared with
            OpenAI and retained for 30 days in accordance with their
            privacy principles.
        
        
            Please do not ask questions that use sensitive or confidential
            information.
        
        Read the full Terms & Conditions.